Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2
- 1 August 1998
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 32 (2), 360-367
- https://doi.org/10.1016/s0735-1097(98)00225-3
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1995
- Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1992
- A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart FailureNew England Journal of Medicine, 1991
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Effect of Captopril on Progressive Ventricular Dilatation after Anterior Myocardial InfarctionNew England Journal of Medicine, 1988
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril.Circulation, 1985
- Influence of chronic captopril therapy on the infarcted left ventricle of the rat.Circulation Research, 1985
- Effects of Captopril on Limiting Infarct Size in Conscious DogsJournal of Cardiovascular Pharmacology, 1984
- Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor.Circulation, 1982